Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P36
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
3 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -11.26% |
| Q3 2025 | -11.88% |
| Q2 2025 | -14.77% |
| Q1 2025 | -21.18% |
| Q4 2024 | 35.62% |
| Q3 2024 | -14.64% |
| Q2 2024 | -13.06% |
| Q1 2024 | -10.57% |
| Q4 2023 | -19.40% |
| Q3 2023 | 30.76% |
| Q2 2023 | -13.30% |
| Q1 2023 | -14.03% |
| Q4 2022 | 21.11% |
| Q3 2022 | -6.31% |
| Q2 2022 | -8.54% |
| Q1 2022 | -8.21% |
| Q4 2021 | -7.31% |
| Q3 2021 | -1.96% |
| Q2 2021 | -0.44% |
| Q1 2021 | -14.56% |
| Q4 2020 | 108.20% |
| Q3 2020 | -9.31% |
| Q2 2020 | -7.29% |
| Q1 2020 | -6.91% |
| Q4 2019 | 21.59% |
| Q3 2019 | -8.71% |
| Q2 2019 | 28.53% |
| Q1 2019 | -8.74% |
| Q4 2018 | 19.47% |
| Q3 2018 | -9.52% |
| Q2 2018 | -15.50% |
| Q1 2018 | -33.16% |
| Q4 2017 | -6.27% |
| Q3 2017 | -11.22% |
| Q2 2017 | -9.06% |
| Q1 2017 | -14.24% |
| Q4 2016 | -14.07% |
| Q3 2016 | -11.90% |
| Q2 2016 | -4.55% |
| Q1 2016 | -8.80% |